These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25994197)

  • 21. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer.
    Inoue M; Minami M; Sawabata N; Utsumi T; Kadota Y; Shigemura N; Okumura M
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1445-9. PubMed ID: 20137967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?
    Hishida T; Yoshida J; Maeda R; Ishii G; Aokage K; Nishimura M; Nagai K
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):772-7. PubMed ID: 22864791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Result of the 6-min walk test is an independent prognostic factor of surgically treated non-small-cell lung cancer.
    Marjanski T; Badocha M; Wnuk D; Dziedzic R; Ostrowski M; Sawicka W; Rzyman W
    Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):368-374. PubMed ID: 30203070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
    Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses.
    Suzuki K; Nagai K; Yoshida J; Nishimura M; Takahashi K; Yokose T; Nishiwaki Y
    Cancer; 1999 Nov; 86(10):1976-84. PubMed ID: 10570421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Frequency and Prognostic Impact of Pathological Microscopic Vascular Invasion According to Tumor Size in Non-Small Cell Lung Cancer.
    Shimada Y; Saji H; Kato Y; Kudo Y; Maeda J; Yoshida K; Hagiwara M; Matsubayashi J; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Chest; 2016 Mar; 149(3):775-85. PubMed ID: 26379115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected.
    Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Kawamura M
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):14-20. PubMed ID: 25878187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm.
    Hung JJ; Jeng WJ; Hsu WH; Lin SF; Hsieh CC; Huang BS; Huang MH; Liu JS; Chou TY; Wu YC
    Eur Respir J; 2010 Dec; 36(6):1355-61. PubMed ID: 20516056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.
    Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG
    J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary middle lobectomy for non-small-cell lung cancer: effectiveness and prognostic implications.
    Mazza F; Ferrari E; Maineri P; Venturino M; Dozin B; Ratto GB
    Eur J Cardiothorac Surg; 2015 Dec; 48(6):e117-23. PubMed ID: 26374866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
    Park SY; Cho A; Yu WS; Lee CY; Lee JG; Kim DJ; Chung KY
    J Nucl Med; 2015 Jan; 56(1):45-9. PubMed ID: 25525185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of multiple malignancies on surgical outcomes in patients with 1 cm or smaller non-small cell lung cancer.
    Tsukioka T; Izumi N; Mizuguchi S; Kyukwang C; Komatsu H; Toda M; Hara K; Miyamoto H; Nishiyama N
    Int J Clin Oncol; 2018 Feb; 23(1):66-72. PubMed ID: 28864833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Margins on Outcomes After Wedge Resection for Stage I Non-Small Cell Lung Cancer.
    Wolf AS; Swanson SJ; Yip R; Liu B; Tarras ES; Yankelevitz DF; Henschke CI; Taioli E; Flores RM;
    Ann Thorac Surg; 2017 Oct; 104(4):1171-1178. PubMed ID: 28669499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging surveillance and survival for surgically resected non-small-cell lung cancer.
    Backhus LM; Farjah F; Liang CK; He H; Varghese TK; Au DH; Flum DR; Zeliadt SB
    J Surg Res; 2016 Jan; 200(1):171-6. PubMed ID: 26231974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Implications of Transbronchial Biopsy for Surgically-resected Non-small Cell Lung Cancer.
    Yasukawa M; Sawabata N; Kawaguchi T; Kawai N; Taniguchi S
    In Vivo; 2018; 32(3):691-698. PubMed ID: 29695580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC).
    Jefferson MF; Pendleton N; Faragher EB; Dixon GR; Myskow MW; Horan MA
    Br J Cancer; 1996 Aug; 74(3):456-9. PubMed ID: 8695364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease.
    Gajra A; Newman N; Gamble GP; Abraham NZ; Kohman LJ; Graziano SL
    Lung Cancer; 2003 Oct; 42(1):51-7. PubMed ID: 14512187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphatic invasion is a more significant prognostic factor than visceral pleural invasion in non-small cell lung cancer with tumours of 3 cm or less.
    Moon Y; Park JK; Lee KY; Sung SW
    Respirology; 2017 Aug; 22(6):1179-1184. PubMed ID: 28382791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.